Resolute Advisors LLC Vertex Pharmaceuticals Inc Transaction History

Resolute Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $5,487 - $6,926	-31 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $7,981 - $8,931	-44 Reduced 58.67%	31 $6,000
Q2 2021 Dec 27, 2021	BUY	$187.49 - $221.1 $14,061 - $16,582	75 New	75 $15,000
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $14,061 - $16,582	-75 Closed	0 $0
Q1 2021 Dec 27, 2021	BUY	$207.02 - $241.31 $15,526 - $18,098	75 New	75 $7,000
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $1,035 - $1,206	-5 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $1,035 - $1,380	5 New	5 $1,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Resolute Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Resolute Advisors LLC with notifications on news.